研究目的
Investigating the use of mesenchymal stem cells (MSCs) and their secreted microvesicles containing assembled gold nanostars (GNS) for targeted photothermal therapy of prostate cancer.
研究成果
The study demonstrates that MSCs and their secreted microvesicles can effectively deliver GNS for targeted photothermal therapy of prostate cancer, showing promising results in both intratumoral and intravenous delivery models.
研究不足
The study primarily focuses on prostate cancer and the specific mechanism of GNS release and photothermal therapy. The applicability to other cancer types and the long-term effects of MSC-based therapy need further investigation.
1:Experimental Design and Method Selection:
The study utilized MSCs as carriers for GNS, focusing on their ability to assemble and release GNS clusters into microvesicles under light control.
2:Sample Selection and Data Sources:
Human umbilical cord-derived MSCs and prostate cancer cell lines (PC-3, DU145, LNCaP) were used.
3:List of Experimental Equipment and Materials:
Gold nanostars (GNS), TAT peptide, photoacoustic imaging, and photothermal therapy equipment.
4:Experimental Procedures and Operational Workflow:
MSCs were loaded with TAT-GNS, and their migration, GNS release, and photothermal effects were evaluated in vitro and in vivo.
5:Data Analysis Methods:
Flow cytometry, TEM, confocal microscopy, and photoacoustic imaging were used for analysis.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容